1. Home
  2. ANVS vs SOL Comparison

ANVS vs SOL Comparison

Compare ANVS & SOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • SOL
  • Stock Information
  • Founded
  • ANVS 2008
  • SOL 2005
  • Country
  • ANVS United States
  • SOL United States
  • Employees
  • ANVS N/A
  • SOL N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • SOL Semiconductors
  • Sector
  • ANVS Health Care
  • SOL Technology
  • Exchange
  • ANVS Nasdaq
  • SOL Nasdaq
  • Market Cap
  • ANVS 92.6M
  • SOL 89.7M
  • IPO Year
  • ANVS 2020
  • SOL 2008
  • Fundamental
  • Price
  • ANVS $2.13
  • SOL $1.66
  • Analyst Decision
  • ANVS Strong Buy
  • SOL Buy
  • Analyst Count
  • ANVS 6
  • SOL 3
  • Target Price
  • ANVS $31.40
  • SOL $3.83
  • AVG Volume (30 Days)
  • ANVS 684.1K
  • SOL 179.7K
  • Earning Date
  • ANVS 03-31-2025
  • SOL 03-27-2025
  • Dividend Yield
  • ANVS N/A
  • SOL N/A
  • EPS Growth
  • ANVS N/A
  • SOL N/A
  • EPS
  • ANVS N/A
  • SOL N/A
  • Revenue
  • ANVS N/A
  • SOL $102,489,000.00
  • Revenue This Year
  • ANVS N/A
  • SOL N/A
  • Revenue Next Year
  • ANVS N/A
  • SOL $47.66
  • P/E Ratio
  • ANVS N/A
  • SOL N/A
  • Revenue Growth
  • ANVS N/A
  • SOL 25.98
  • 52 Week Low
  • ANVS $2.08
  • SOL $1.41
  • 52 Week High
  • ANVS $20.00
  • SOL $3.00
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 18.43
  • SOL 36.27
  • Support Level
  • ANVS $2.08
  • SOL $1.67
  • Resistance Level
  • ANVS $2.79
  • SOL $1.79
  • Average True Range (ATR)
  • ANVS 0.32
  • SOL 0.08
  • MACD
  • ANVS -0.06
  • SOL -0.00
  • Stochastic Oscillator
  • ANVS 2.08
  • SOL 18.52

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.

About SOL Emeren Group Ltd each representing 10 shares

Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has global Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. The company generates maximum revenue from Poland.

Share on Social Networks: